InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,280.00
(
0.60%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
86.51
(
1.64%
)
Bitcoin
63,311.73
(
1.14%
)

Replies to post #127457 on Biotech Values

Replies to #127457 on Biotech Values

ghmm

09/28/11 5:25 AM

#127460 RE: genisi #127457

UTHR:

Yeah the study was also a longer duration (24 weeks) then past approved PAH therapies (12 or 16). Still I think the results on the surface looked quite good. I doubt much impact on IV/sub-q use.